Breast Cancer DNA Methylation Profiles Are Associated with Tumor Size and Alcohol and Folate Intake
Open Access
- 29 July 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLoS Genetics
- Vol. 6 (7), e1001043
- https://doi.org/10.1371/journal.pgen.1001043
Abstract
Although tumor size and lymph node involvement are the current cornerstones of breast cancer prognosis, they have not been extensively explored in relation to tumor methylation attributes in conjunction with other tumor and patient dietary and hormonal characteristics. Using primary breast tumors from 162 (AJCC stage I–IV) women from the Kaiser Division of Research Pathways Study and the Illumina GoldenGate methylation bead-array platform, we measured 1,413 autosomal CpG loci associated with 773 cancer-related genes and validated select CpG loci with Sequenom EpiTYPER. Tumor grade, size, estrogen and progesterone receptor status, and triple negative status were significantly (Q-values PPP<0.0001) associated with methylation class membership. Breast cancer prognostic characteristics and risk-related exposures appear to be associated with gene-specific tumor methylation, as well as overall methylation patterns. The current standard prognostic indicator for breast cancer is tumor-node-metastasis staging; though, as population-based studies and clinical trials are conducted, molecular characterization of disease is beginning to allow improved markers of prognosis and assist clinicians in choosing the most appropriate therapies. We investigated DNA methylation profiles in over 160 well annotated breast tumor samples and found significant relationships with standard and other known predictors of prognosis, as well as established risk factors for disease: alcohol intake and dietary folate. Recently the United States National Cancer Institute Cancer Biomarkers Research Group articulated a need for a “Strategic Approach to Validating Methylated Genes as Biomarkers for Breast Cancer,” and our work is extremely responsive to this call for a national strategy. Recognizing the increasing use of pre-operative chemotherapy for patients with operable, early-stage disease, there is added complexity in breast cancer staging. Since chemotherapy can considerably decrease tumor size, it is still unclear whether pre-operative or post-operative stage best informs prognosis and treatment decisions for patients electing pre-operative chemotherapy. However, our data clearly illustrate the promise of tumor DNA methylation for augmenting tumor staging and can be attained with minimal tissue in a pre-operative context.Keywords
This publication has 40 references indexed in Scilit:
- Microarray-based Transcriptional and Epigenetic Profiling of Matrix Metalloproteinases, Collagens, and Related Genes in CancerJournal of Biological Chemistry, 2010
- Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI ratsCarcinogenesis: Integrative Cancer Research, 2009
- Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinomaCarcinogenesis: Integrative Cancer Research, 2009
- Epigenetic Profiles Distinguish Pleural Mesothelioma from Normal Pleura and Predict Lung Asbestos Burden and Clinical OutcomeCancer Research, 2008
- Agglomerative Epigenetic Aberrations Are a Common Event in Human Breast CancerCancer Research, 2008
- Regulation by P2X7: Epithelial Migration and Stromal Organization in the CorneaInvestigative Opthalmology & Visual Science, 2008
- The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern CaliforniaCancer Causes & Control, 2008
- Meta-analysis of Studies of Alcohol and Breast Cancer with Consideration of the Methodological IssuesCancer Causes & Control, 2006
- High-throughput DNA methylation profiling using universal bead arraysGenome Research, 2006
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987